The MspI polymorphism of the apolipoprotein A-II gene as a modulator of the dyslipidemic state found in visceral obesity

Atherosclerosis

Volumn 128, Issue 2, 1997, Pages 183-190

  Vohl, Marie Claude ^a   Lamarche, Benoît ^a   Bergeron, Jean ^a   Moorjani, Sital ^a   Prud'homme, Denis ^b   Nadeau, André ^a   Tremblay, Angelo ^b   Lupien, Paul J ^a   Bouchard, Claude ^b   Després, Jean Pierre ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

apo A II; free fatty acids; HDL cholesterol; hyperinsulinemia; visceral obesity

Indexed keywords

APOLIPOPROTEIN A2; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MALE; OBESITY; PRIORITY JOURNAL;

ADIPOSE TISSUE; ADULT; ALLELES; APOLIPOPROTEIN A-II; CHOLESTEROL, HDL; DEOXYRIBONUCLEASE HPAII; GENE FREQUENCY; GENES; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HYPERINSULINISM; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, GENETIC; VISCERA;

EID: 0031052158     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)05985-0     Document Type: Article

References (45)

1. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev 1994;74:761.
2. Després JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 1990;10:497.
3. Björntorp P. Abdominal obesity and the development of noninsulin-dependent diabetes mellitus. Diabetes Metab Rev 1988;4:615.
4. Després JP. Dyslipidemia and obesity. Baillières Clinical Endocrinology and Metabolism 1994;8:629-660.
5. DeFronzo RA, Ferrannini E. Hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173.
6. Després JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Genetic aspects of susceptibility to obesity and related dyslipidemias. Mol Cell Biochem 1992;113:151.
7. Després JP, Lamarche B. Effects of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular disease. Nutr Res Rev 1993;6:137.
8. Pérusse L, Després JP, Lemieux S, Rice T, Rao DC, Bouchard C. Familial aggregation of abdominal visceral fat level: results from the Quebec Family Study. Metabolism 1996;45:378-382.
9. Pouliot MC, Després JP, Moorjani S, Lupien PJ, Tremblay A, Bouchard C. Apolipoprotein E polymorphism alters the association between body fatness and plasma lipoproteins in women. J Lipid Res 1990;31:1023.
10. Després JP, Verdon MF, Moorjani S, Pouliot MC, Nadeau A, Bouchard C, Tremblay A, Lupien PJ. Apolipoprotein E polymorphism modifies relation of hyperinsulinemia to hypertriglyceridemia. Diabetes 1993;42:1474.
11. Pouliot MC, Després JP, Dionne FT, Vohl MC, Moorjani S, Prud'homme D, Bouchard C, Lupien PJ. Apo B-100 gene EcoRI polymorphism: relations to plasma lipoprotein changes associated with abdominal visceral obesity. Arterioscler Thromb 1994;14:527.
12. Vohl MC, Lamarche B, Moorjani S, Prud'homme D, Nadeau A, Bouchard C, Lupien PJ, Després JP. The lipoprotein lipase HindIII polymorphism modulates plasma triglyceride levels in visceral obesity. Arterioscler Thromb Vasc Biol 1995;15:714.
13. Pouliot MC, Després JP, Nadeau A, Moorjani S, Prud'homme D, Lupien PJ, Tremblay A, Bouchard C. Visceral obesity in men: associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 1992;41:826.
14. Gwynne JT. High-density lipoprotein cholesterol levels as a marker of reverse cholesterol transport. Am J Cardiol 1989;64:10G.
15. Deeb SS, Takata K, Peng R, Kajiyama G, Albers JJ. A splice-junction mutation responsible for familial apolipoprotein A-II deficiency. Am J Hum Genet 1990;46:822.
16. Hedrick CC, Lusis AJ. Apolipoprotein A-II: a protein in search of a function. Can J Cardiol 1994;10(4):453.
17. Chen CH, Albers JJ. Stimulation of LCAT activity by apo A-II in the presence of apolipoprotein A-I. Eur J Biochem 1986;155:589.
18. 2 subfractions with hepatic lipase. Circulation 1990;82(Suppl 111):558.
19. Fager G, Winklund O, Olofsson SO, Wilhemsen L, Bondjers G. Multivariate analyses of serum apolipoproteins and risk factors in relation to acute myocardial infarction. Arteriosclerosis 1981;1:273.
20. Albers JJ, Cheung MC, Hazzard WR. High density lipoproteins in MI survivors. Metabolism 1978;27:479.
21. Kempen HJ, Van Gent CM, Buytenhek R, Buis B. Association of cholesterol concentration in LDL, HDL, and HDL subtractions, and of apo A-I and A-II with coronary stenosis and left ventricular function. J Lab Clin Med 1987;109:19.
22. Parra HJ, Arveiler D, Evans AE, Cambou JP, Amouyel P, Bingham A, McMaster D, Schaffer P, Douste-Blazy P, Luc G, Richard SL, Ducimetière P, Fruchart JC, Cambien F. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study. Arterioscler Thromb 1992;12:701.
23. 3 cholesterol, apo A-I and apo A-II, and increased risk of myocardial infarction. Circulation 1992;85:22.
24. Civeira F, Genest J, Pocovi M, Salem DN, Herbert PN, Wilson PWF, Schaefer EJ, Ordovas JM. The MspI restriction fragment length polymorphism 3′ to the apolipoprotein A-II gene: relationships with lipids, apolipoproteins, and premature coronary artery disease. Atherosclerosis 1992;92:165.
25. Scott J, Knott TJ, Priestly LM, Robertson ME. High-density lipoprotein composition is altered by a common DNA polymorphism adjacent to apoprotein A-II gene in man. Lancet 1985;1:771.
26. Ferns GAA, Shelley CS, Stocks J, Rees A, Paul H, Baralle F, Galton DJ. A DNA polymorphism of the apoprotein A-II gene in hypertriglyceridemia. Hum Genet 1986;74:302.
27. Behnke AR, Wilmore JH. Evaluation and Regulation of Body Build and Composition. Englewood Cliffs, NJ: Prentice-Hall, 1974;20-37.
28. Siri WE. The gross composition of the body. Adv Biol Med Phys 1956;4:239.
29. Meneely GR, Kaltreider NL. Volume of the lung determined by helium dilution. J Clin Invest 1949;28:129.
30. Standardization of anthropometric measurements. In: Lohman T, Roche A and Martorel R (Eds.) The Airlie (VA) Consensus Conference. Champaign, IL: Human Kinetics Publishers, 1988;39-80.
31. Ferland M, Després JP, Tremblay A, Pinault S, Nadeau A, Moorjani S, Lupien PJ, Thériault G, Bouchard C. Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements. Br J Nutr 1989;61:139.
32. 40K, and tritium. Am J Physiol 1986;250:E736.
33. Kvist H, Tylen U, Sjöström L. Adipose tissue volume determination in women by computed tomography: technical considerations. Int J Obes 1986;10:53.
34. Richterich R, Dauwalder H. Zur Bestimmung der Plasmaglukosekonzentration mit der Hexokinase-glucose-6-phosphat-dehydrogenase-method. Schweiz Med Wochenschr 1971;101:615.
35. Desbuquois B, Aurbach GD. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 1971;37:732.
36. Noma A, Okabe H, Kita M. A new colorimetric microdetermination of free fatty acids in serum. Clin Chim Acta 1973;43:317.
37. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345.
38. Burstein M, Samaille J. Sur un dosage rapide du cholestérol lié aux alpha et aux bêta lipoprotéines du sérum. Clin Chem Acta 1960;5:609.
39. Moorjani S, Dupont A, Labrie F, Lupien PJ, Brun D, Gagné C, Giguère M, Bélanger A. Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma. Metabolism 1987;36:244.
40. Després JP, Lamarche B. Effects of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular disease. Nutr Res Rev 1993;6:137.
41. Kessling AM, Rajput-Williams J, Bainton D, Scott J, Miller NE, Baker I, Humphries SE. DNA polymorphisms of the apolipoprotein A-II and AI-CII-AIV genes: a study in men selected for differences in high-density-lipoprotein cholesterol concentration. Am J Hum Genet 1988;42:458.
42. Rajput-Williams J, Eyre J, Nanjee MN, Crook D, Scott J, Miller NE. Plasma lipoprotein lipids in relation to the MspI polymorphism of the apolipoprotein A-II gene in caucasian men. Atherosclerosis 1989;77:31.
43. Thorn JA, Stocks J, Reichl D, Alcolado JC, Chamberlain JC, Galton D. Variability of plasma apolipoprotein (apo) A-II levels associated with an apo A-II gene polymorphism in monozygotic twin pairs. Biochim Biophys Acta 1993;1180:299.
44. Warden CH, Daluiski A, Bu X, Purcell-Huynh DA, De Meester C, Shieh BH, Puppione DL, Gray RM, Reaven GM, Chen YDI, Rotter JI, Lusis AJ. Evidence for linkage of the apolipoprotein A-II locus to plasma apolipoprotein A-II and free fatty acid levels in mice and humans. Proc Natl Acad Sci USA 1993;90:10886.
45. Bu X, Warden CH, Xia YR, De Meester C, Puppione DL, Teruya S, Lokensgard B, Daneshmand S, Brown J, Gray RJ, Rotter JI, Lusis AJ. Linkage analysis of the genetic determinants of high density lipoprotein concentrations and composition: evidence for involvement of the apolipoprotein A-II and cholesteryl ester transfer protein loci. Hum Genet 1994;93:639.